Artiva Biotherapeutics Inc (ARTV) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Artiva Biotherapeutics Inc   (NASDAQ: ARTV)

Artiva Biotherapeutics Inc Profitability Comparisons

Select each Category to receive further Information




ARTV Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 69.56 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) - 72.25 % 55.57 % 38.04 %
Gross Profit Margin 5 Yr. Avg. - 68.86 % 53.76 % 33.44 %
EBITDA Margin (Q2 MRQ) - 20.62 % 19.62 % 20.72 %
EBITDA Margin (Q2 TTM) - 27.23 % 21.02 % 19.28 %
EBITDA Margin 5 Yr. Avg. - 23.3 % 31.89 % 22.83 %
Operating Margin (Q2 MRQ) - 11.28 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) - 16.53 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 6.03 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) - 7.4 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - 15.08 % 12.85 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) - 2.64 % 8.14 % 11.41 %
Net Margin (Q2 TTM) - 11.09 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 6.58 % 6.23 % 9.95 %